Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gitte Thirion"'
Autor:
Sarah Libbrecht, Ann Vankerckhoven, Koen de Wijs, Thaïs Baert, Gitte Thirion, Katja Vandenbrande, Toon Van Gorp, Dirk Timmerman, An Coosemans, Liesbet Lagae
Publikováno v:
Cells, Vol 13, Iss 1, p 7 (2023)
Among cancer diagnoses in women, ovarian cancer has the fifth-highest mortality rate. Current treatments are unsatisfactory, and new therapies are highly needed. Immunotherapies show great promise but have not reached their full potential in ovarian
Externí odkaz:
https://doaj.org/article/2e9bc2a2e7a64637a5d30c33cf2b18b4
Autor:
Ann Vankerckhoven, Thaïs Baert, Matteo Riva, Christine De Bruyn, Gitte Thirion, Katja Vandenbrande, Jolien Ceusters, Ignace Vergote, An Coosemans
Publikováno v:
Translational Oncology, Vol 14, Iss 6, Pp 101076- (2021)
Chemotherapy induces a variety of immunological changes. Studying these effects can reveal opportunities for successful combining chemotherapy and immunotherapy. Immuno-chemotherapeutic combinations in ovarian cancer are currently not generating the
Externí odkaz:
https://doaj.org/article/0ec0490761374d4cacf0cee7395fe6b6
Autor:
Roxanne Wouters, Sara Westrøm, Ann Vankerckhoven, Gitte Thirion, Jolien Ceusters, Sandra Claes, Dominique Schols, Tina B. Bønsdorff, Ignace Vergote, An Coosemans
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 687 (2022)
Novel treatment strategies are needed to provide a better prognosis for ovarian cancer. For this purpose, the current study was designed to evaluate the effects of different types of particle drug carriers on tumor response and on the tumor immune mi
Externí odkaz:
https://doaj.org/article/5f614b79901e4a00a523057f41007f26
Autor:
Thaïs Baert, Ann Vankerckhoven, Matteo Riva, Anaïs Van Hoylandt, Gitte Thirion, Gerhardt Holger, Thomas Mathivet, Ignace Vergote, An Coosemans
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The presence of tumor infiltrating lymphocytes (TILs) is associated with a longer overall survival in advanced stage epithelial ovarian cancer. Despite the prognostic impact of TILs, response to checkpoint-inhibitors and antigen-specific active immun
Externí odkaz:
https://doaj.org/article/a884f2f1798146ddb9bdf3bf6b81fc6d
Autor:
Sandra Claes, Adriaan Vanderstichele, A.S. Van Rompuy, T Van Gorp, Jaak Billen, Jolien Ceusters, Gitte Thirion, Ignace Vergote, Dirk Timmerman, Thaïs Baert, An Coosemans, J. Oosterlynck, Wouter Froyman, A Van Hoylandt, R. Heremans, Tom Bourne, Dominique Schols, E.T.L. Achten, B. Van Calster, Chiara Landolfo
Publikováno v:
Gynecologic Oncology. 159:811-819
Objective To estimate the diagnostic value of tumor and immune related proteins in the discrimination between benign and malignant adnexal masses, and between different subgroups of tumors. Methods In this exploratory diagnostic study, 254 patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54e768296c357a4269a4b975cfe1beb4
https://doi.org/10.1016/j.ygyno.2020.09.025
https://doi.org/10.1016/j.ygyno.2020.09.025
Autor:
Dirk Timmerman, Ignace Vergote, Roxanne Wouters, Christine De Bruyn, An Coosemans, Ann Vankerckhoven, Jolien Ceusters, Chiara Landolfo, Gitte Thirion, Thaïs Baert, Sandra Claes, Dominique Schols
Publikováno v:
Cancers
Cancers; Volume 13; Issue 23; Pages: 5899
Cancers, Vol 13, Iss 5899, p 5899 (2021)
Cancers; Volume 13; Issue 23; Pages: 5899
Cancers, Vol 13, Iss 5899, p 5899 (2021)
Simple Summary The immune system plays an important role in the development and progression of cancer. The current treatments for ovarian cancer (surgery and chemotherapy) create changes in the immune system, but it is not clear how. Nevertheless, if
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c246c7bc06b874a5b4be2ed832661c59
http://europepmc.org/articles/PMC8656504
http://europepmc.org/articles/PMC8656504
Autor:
Sien Bevers, Berckmans Y, Roxanne Wouters, Matteo Riva, Verbeeck J, An Coosemans, Katja Vandenbrande, Ann Vankerckhoven, Gitte Thirion, De Keersmaecker K
IntroductionContrarily to clinical trials, where glioblastoma (GBM) patients are usually heavily pre-treated (surgery, radiotherapy (RT) and temozolomide (TMZ)) before receiving the experimental therapies, in preclinical GBM studies experimental trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c116fb280e1901db7c5c9485fb01ecc3
https://doi.org/10.1101/2021.06.17.448792
https://doi.org/10.1101/2021.06.17.448792
Autor:
B. Van Calster, Wouter Froyman, Chiara Landolfo, An Coosemans, A. Van Rompay, R. Heremans, Lil Valentin, D. Timmerman, J. Oosterlynck, T Van Gorp, Jaak Billen, Tom Bourne, A. C. Testa, Ignace Vergote, Gitte Thirion, Jolien Ceusters
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 56:7-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cfb89ca51ae28d556e5849bb04f8013
https://doi.org/10.1002/uog.22214
https://doi.org/10.1002/uog.22214
Autor:
Gitte Thirion, D. Timmerman, Chiara Landolfo, Tina Verschuere, A Van Hoylandt, A-S Van Rompuy, Ignace Vergote, An Coosemans, A du Bois, Jolien Ceusters, Thaïs Baert
Publikováno v:
Poster exhibition Day 2.
Introduction/Background The KEYNOTE-021 trial showed a beneficial effect of the combination of chemotherapy and immunotherapy in non-small-cell lung cancer, since then multiple trials have studied combination of chemotherapy and immunotherapy. Howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a14aaa94fe5e60155c2ee93181a2493
https://doi.org/10.1136/ijgc-2019-esgo.229
https://doi.org/10.1136/ijgc-2019-esgo.229